Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3637092 | 1.00 | MAPT (0.39) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL3634453 | 0.93 | GRIK1 (0.41) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL15760500 | 0.88 | SMN1; SMN2 (0.34) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL2286672 | 0.85 | MAPT (0.40) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL2516533 | 0.85 | MAPT (0.40) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL557341 | 0.85 | MAPT (0.35) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| SCHEMBL8628768 | 0.83 | TDP1 (0.35) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL6573325 | 0.83 | MAPT (0.39) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL2302935 | 0.83 | MAPT (0.39) | MAPTCACNA1BAPBA1CYP3A4TSHR | |
| Hydrochloric Acid SCHEMBL2302945 | 0.83 | MAPT (0.39) | MAPTCACNA1BAPBA1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020017390-A1 | LACTIC ACID BACTERIUM, NATURAL IMMUNE ACTIVATING AGENT DERIVED FROM LACTIC ACID BACTERIUM, AND PREVENTIVE/THERAPEUTIC DRUG FOR INFECTION AND FOOD OR BEVERAGE | 株式会社ゲノム創薬研究所 | 2020-01-23 | — | — | WO | disclosed |
| US-8343212-B2 | Polymer coatings on medical devices | Biotectix, LLC (US) | 2013-01-01 | — | — | US | disclosed |
| EP-2155275-B1 | POLYMER COATINGS ON MEDICAL DEVICES | BIOTECTIX LLC (US) | 2012-09-05 | — | — | EP | disclosed |
| US-20100312331-A1 | POLYMER COATINGS ON MEDICAL DEVICES | CHAMELEON BIOSURFACES LIMITED (GB) | 2010-12-09 | — | — | US | disclosed |
| EP-2155275-A2 | POLYMER COATINGS ON MEDICAL DEVICES | Chameleon Biosurfaces Limited (GB) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008139200-A2 | POLYMER COATINGS ON MEDICAL DEVICES | CHAMELEON BIOSURFACES LIMITED (GB) | 2008-11-20 | — | — | WO | disclosed |